SCHEMBL29413367

SCHEMBL29413367

O=C(c1cscc1Nc1ccc(I)cc1F)N1CC(O)C1

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 20/20 0.66
MAP2K2 P36507 15/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188813 1.00 MAP2K1 (0.66) MAP2K1MAP2K2
SCHEMBL29413483 0.90 MAP2K1 (0.61) MAP2K1MAP2K2
SCHEMBL189133 0.90 MAP2K1 (0.61) MAP2K1MAP2K2
SCHEMBL28217741 0.83 MAP2K1 (0.49) MAP2K1MAP2K2
SCHEMBL29413594 0.81 MAP2K1 (0.68) MAP2K1MAP2K2
SCHEMBL1488384 0.81 MAP2K1 (0.68) MAP2K1MAP2K2
SCHEMBL29413551 0.80 MAP2K1 (1.00) MAP2K1MAP2K2
SCHEMBL189188 0.80 MAP2K1 (1.00) MAP2K1MAP2K2
SCHEMBL188960 0.79 MAP2K1 (0.63) MAP2K1MAP2K2
SCHEMBL29413520 0.79 MAP2K1 (0.63) MAP2K1MAP2K2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109053523-B Azetidines as MEK inhibitors for the treatment of proliferative diseases 埃克塞利希斯股份有限公司 2022-03-25 CN disclosed